Back to search

University of British Columbia

Integrating sex and gender-based analysis in pharmacoepidemiologic studies of medication adherence

Abstract

dc:description

Introduction: Medication adherence is a complex health behaviour affected by a range of biological and psychosocial factors including sex and gender. The objectives of my thesis research are to: 1) conduct a comprehensive analysis of the burden and predictors of cost-related non-adherence (CRNA); 2) examine the relationship between sex and gender with CRNA; 3) evaluate the impact of the COVID-19 pandemic on adherence to prescription drugs used for chronic diseases; and 4) characterize long-term trajectories of these drug groups. Methods: Using data pooled from 5 cycles of Canadian Community Health Survey (CCHS) cycles, I identified demographic, health, and healthcare system predictors of CRNA (Part 1) and compared 3 approaches to measuring the impact of gender on CRNA (Part 2). Then, using linked administrative health data on all physician visits, hospital admissions, and all dispensed medications in British Columbia, I performed interrupted time-series analysis to estimate changes in adherence one year before and after the COVID-19 pandemic (Part 3) and used group-based trajectory models to identify long-term adherence patterns and multinomial logistic regression to identify their associated factors (Part 4). Results: Part 1: 4.9% (95% CI, 4.7% – 5.0%) of Canadians experienced CRNA. Part 2: Inclusion of a composite measure of gender showed both feminine gender-related characteristics (aOR, 1.97; 95% CI, 1.16 – 3.36) as well as female sex (aOR 1.35; 95% CI, 1.12 – 1.63) were independently associated with CRNA. Part 3: Adherence, measured by proportion of days covered (PDC), was 48.8% 1-year before and 49.1% 1-year after the pandemic (p<0.05) among all included drug groups, with no change in slope (-0.06%; 95% CI: -0.13% – 0.01%; p=0.10). Part 4: Of 4 distinct adherence trajectories, there were statistically significant differences in the sex distribution in the ‘High and increasing adherence’ (41.0% male vs. 37.2% female; p<0.05), and ‘Low and decreasing adherence’ (23.8% male vs. 27.6% female; p<0.05), with female sex consistently being associated with poorer adherence trajectories in logistic regression analysis. Conclusion: This thesis provides real-world evidence on adherence to medications and offers pragmatic methods of measuring the diverse, nuanced, and intersectional dimensions of sex and gender using ‘big’ data.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Pharmaceutical Sciences
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rebić, Nevena
Contributors dc:contributor
  • De Vera, Mary

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/89074

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Rebić, Nevena. Integrating sex and gender-based analysis in pharmacoepidemiologic studies of medication adherence. doctoral thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/89074